102 related articles for article (PubMed ID: 4867045)
1. Current status of catecholamines and their implication in various diseases.
Uddin M; Green P
Manit Med Rev; 1967 Dec; 47(10):561-6. PubMed ID: 4867045
[No Abstract] [Full Text] [Related]
2. [Clinical aspects of catecholamine secretion disorders].
Nakano Y; Sugano Y; Esaki T; Shimbo S; Manabe S
Naika; 1967 Sep; 20(3):457-74. PubMed ID: 4296851
[No Abstract] [Full Text] [Related]
3. Catecholamines and neurologic diseases (second of two parts).
Moskowitz MA; Wurtman RJ
N Engl J Med; 1975 Aug; 293(7):332-8. PubMed ID: 125386
[No Abstract] [Full Text] [Related]
4. Trophic functions of the neuron. V. Familial dysautonomia. Familial dysautonomia: clinical and pathophysiological aspects.
Riley CM
Ann N Y Acad Sci; 1974 Mar; 228(0):283-7. PubMed ID: 4526281
[No Abstract] [Full Text] [Related]
5. Familial dysautonomia.
Dancis J; Smith AA
N Engl J Med; 1966 Jan; 274(4):207-9. PubMed ID: 5902619
[No Abstract] [Full Text] [Related]
6. Catecholamines in neuropsychiatric states.
Kety SS
Pharmacol Rev; 1966 Mar; 18(1):787-98. PubMed ID: 5323770
[No Abstract] [Full Text] [Related]
7. [Pheochromocytoma with diabetes mellitus revealed by acute circulatory insufficiency].
Passa P; Gourgon R; Motte G; Lorente P; Maria J; Canivet J
Nouv Presse Med; 1972 Jan; 1(4):245-8. PubMed ID: 5010121
[No Abstract] [Full Text] [Related]
8. Catecholamine metabolism in health and disease.
Hoeldtke R
Metabolism; 1974 Jul; 23(7):663-83. PubMed ID: 4365898
[No Abstract] [Full Text] [Related]
9. [Vasoactive endogenous substances and pharmacological agents with peripheral action].
Muscholl E
Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1967; 188(2):138-47. PubMed ID: 5599743
[No Abstract] [Full Text] [Related]
10. Biochemical aspects of schizophrenia.
Lewis ME
Essays Neurochem Neuropharmacol; 1980; 4():1-67. PubMed ID: 6104597
[No Abstract] [Full Text] [Related]
11. Brain catecholamines and neurological disease.
Wurtman RJ; Moskowitz MA
Trans Am Neurol Assoc; 1974; 99():149-59. PubMed ID: 4282535
[No Abstract] [Full Text] [Related]
12. [Hypertension sensitive to adrenolytic, agents, not caused by a pheochromocytoma].
PELLEGRINI P
Minerva Cardioangiol; 1962 Mar; 10():157-81. PubMed ID: 14484955
[No Abstract] [Full Text] [Related]
13. [Functional adrenergic attacks with paroxysmal arterial hypertension].
Stoica T; Coculescu M; Chivu V; Iosif G
Med Interna (Bucur); 1970 Jan; 22(1):61-7. PubMed ID: 5527975
[No Abstract] [Full Text] [Related]
14. The role of catecholamines in circulatory diseases.
Abboud FM
Adv Intern Med; 1969; 15():17-49. PubMed ID: 4908617
[No Abstract] [Full Text] [Related]
15. A rare cause of cardiogenic shock: catecholamine cardiomyopathy of pheochromocytoma.
Imperadore F; Azzolini M; Piscioli F; Pusiol T; Capitanio A; Vergara G
Ital Heart J; 2002 Jun; 3(6):375-8. PubMed ID: 12116803
[TBL] [Abstract][Full Text] [Related]
16. [Modifications of catecholamine metabolism under the effect of a decarboxylase inhibitor associated with L-dopa and desipramine in patients with depressive and parkinsonian syndromes].
Geissbuhler F; Bartholini G; Gaillard JM; Tissot R
Encephale; 1971; 60(3):189-209. PubMed ID: 5119348
[No Abstract] [Full Text] [Related]
17. Anesthetic management of pheochromocytoma employing halothane and beta adrenergic blockade. A report of fourteen cases.
Cooperman LH; Engelman K; Mann PE
Anesthesiology; 1967; 28(3):575-82. PubMed ID: 6023528
[No Abstract] [Full Text] [Related]
18. [Clinical aspects of the effect of catecholamines].
Hillestad L
Tidsskr Nor Laegeforen; 1970 Nov; 90(21):1993-6. PubMed ID: 5477860
[No Abstract] [Full Text] [Related]
19. [Stress and catecholamines in cardiovascular pathology].
Dimitriu CG; Karassi A; Manu P; Gavrilă F
Med Interna (Bucur); 1971 Oct; 23(10):1155-67. PubMed ID: 4942486
[No Abstract] [Full Text] [Related]
20. [Catecholamines and cardiovascular pathology].
Popovici D
Stud Cercet Endocrinol; 1966; 17(4):319-30. PubMed ID: 5982192
[No Abstract] [Full Text] [Related]
[Next] [New Search]
